Search

everythinglearnresearchcommunity

for

Search:↓

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Current treatments for alopecia show no significant long-term benefits.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

The document is a detailed medical reference on skin and genetic disorders.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Targeted cancer therapies often cause serious skin problems that need careful management.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Hair loss requires customized treatments based on its various causes and types.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.